We preview the 1H’18 results due in early August. The 18 June trading update confirmed trading was consistent with FY guidance, but we think investors should recognise the split between
We have repeatedly asserted that providers of Home Collect Credit (HCC) need to understand their customers’ thinking in order to lend profitably. Equally, to properly appreciate the risks and rewards
City of London Investment Group (LON:CLIG) published a trading statement this morning, covering FY2018. Profits are expected to be almost in line with Hardman & Co forecasts, with PBT of
Allergy Therapeutics Plc (LON:AGY) is a long-established specialist in the prevention, diagnosis, and treatment of allergies. Pollinex Quattro (PQ) Grass, the subcutaneous allergy immunotherapy (AIT), continues to gain market share
Video Assistant Referee (VAR): This VAR was conceived in 2010 by the Royal Netherlands Football Association (KNVB) but it was seven years later, in April 2017, that it had its
Shortly after its deal with Hindustan Times, Koovs Plc (LON:KOOV) has announced an even more important tie-up with a major Indian partner: Future Lifestyle Fashions Ltd (FLFL), part of The
Evgen Pharma Plc (LON:EVG) is a virtual pharmaceutical company focused on the development of a synthetic version of a natural product, sulforaphane, which is known to modulate key signalling pathways
Genedrive plc (LON:GDR) is a commercial-stage company focused on point-of-care molecular diagnostics. Its Genedrive® molecular diagnostic testing platform is at the forefront of this technology, offering a rapid, low-cost, simple-to-use
Redx Pharma Plc (LON:REDX) new management team is focusing its financial resources (ca.£10m) on progressing its lead candidates in oncology and fibrotic disease into the clinic. Although the first patient
Warpaint London Plc (LON:W7L) is a UK-based, colour cosmetics specialist that sells creative, design-focused and high-quality cosmetics at affordable prices. Warpaint’s flagship brand, W7, has established a loyal customer base,
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
